Generics News

Generics News

Mylan Launches Generic Vivelle-DOT

Mylan announced the launch of Estradiol Transdermal System, the generic version of Novartis' Vivelle-DOT.

Lannett Approved for Generic Cosopt

Lannett announced that it has received approval for Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, the generic version of Oak's Cosopt.

Dr. Reddy's Launches Generic Valcyte

Dr. Reddy's Laboratories announced the launch of Valganciclovir Tablets, the generic version of Valcyte.

Teva Launches Generic Xopenex Concentrate

Teva announced the launch of Levalbuterol Inhalation Solution, the generic version of Xopenex Inhalation Solution Concentrate.

Mylan Launches Generic Orapred ODT

Mylan announced the launch of Prednisolone Sodium Phosphate Orally Disintegrating Tablets, the generic of Shionogi's Orapred ODT.

Mylan Launches Generic Robaxin Injection

Mylan announced the launch of Methocarbamol Injection, the generic version of Hikma Maple's Robaxin Injection.

First Generic Versions of Celebrex Launched

Teva, Mylan, Actavis, and Lupin announced the launch of Celecoxib Capsules, the generic version of Pfizer's Celebrex.

Tentative Approval Granted for Pediatric HIV-1 Combo Drug

Mylan announced it has received tentative approval from the Food and Drug Administration (FDA) for Abacavir/Lamivudine Tablets for Oral Suspension for the treatment of pediatric HIV-1 infection.

Perrigo Launches Generic Pennsaid

Perrigo announced it has received final approval from the Food and Drug Administration (FDA) for Diclofenac Sodium Topical Solution, the generic version of Mallinckrodt's Pennsaid.

Actavis Launches Generic Intuniv

Actavis announced the launch of Guanfacine HCl, the generic version of Shire's Intuniv.